Skip to main content
OpenTrials
Completed

NCT Number: NCT05694156

Musical Attention Control and Executive Function Training for Adults With MDD

The investigators have developed music-based cognitive training sessions derived from Neurologic Music Therapy (NMT) techniques. The music-based cognitive training sessions will address areas of attention and executive function, which appear to progress over time and worsen as an individual experiences more episodes of depression. The aim of this pilot is to test 8-weeks of music-based cognitive training to improve cognitive function among adults with major depressive disorder.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

St. Michael's Hospital

Toronto, Ontario, M5B 1M8, Canada

About this study

Major Depressive Disorder (MDD) is a lifelong condition and is the leading cause of disability in the world. MDD is a multifaceted mood disorder and due to its complex nature, this mental health diagnosis affects emotional, behavioural, and cognitive processing. Cognitive dysfunction appears to progress over time and worsens as the individual experiences more episodes of depression. Because of this, it is critical to continue to investigate and formulate effective treatment that can target and improve not only depressive symptoms, but also address overall cognitive function. Thus, the investigators propose implementing music-based cognitive training derived from Neurologic Music Therapy (NMT) techniques to address cognitive dysfunction experienced by adults diagnosed with MDD. Music-based interventions, specifically from the NMT approach have been shown to physically change the human brain when working on cognition in areas of attention and executive function, however little is known of these applications with adults with MDD. The aim of this pilot is to test 8-weeks of music-based cognitive training to improve cognitive function among adults with MDD.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Clinical diagnosis of MDD meeting the Diagnostic and Statistical Manual Diploma in Social Medicine (DSM-V) criteria
  • Experiencing suicidal ideation in the past week (Beck Scale for Suicide Ideation >10)
  • Have received more than 12 sessions of psychotherapy
  • Stable medication use > 4 weeks
  • Ability to undergo music-based cognitive training sessions in English
  • Capable of giving informed consent

Exclusion criteria

  • The presence of cognitive impairment that would limit consent or understanding of neurologic music therapy
  • The presence of active psychosis
  • The presence of mood and suicidal symptom severity requiring immediate treatment
  • Hearing impairment
  • Participation in music therapy 6 months prior to study
  • Private music lessons for a period of 1 year prior to study
  • Unwilling or unable to provide informed consent

Treatment and study plan

Music-based cognitive training

Other

8-week music-based cognitive training

Primary outcomes

  1. Change in inhibition using the Go/No Go Task

    Time frame: From baseline to 8-weeks

    This cognitive task measures response time, accuracy, commission errors, omission errors, and reaction time variability.

  2. Change in working memory capacity using the Digit Span Forward and Backward Test

    Time frame: From baseline to 8-weeks

    This cognitive task measures span length, correct recall, error rate, and reaction time.

  3. Change in cognitive flexibility and executive control using the Shifting Attention test

    Time frame: From baseline to 8-weeks

    This cognitive task measures the ability to shift attention between different stimuli, assessing the speed and accuracy with which the individual can shift their attention and switch between different rules.

  4. Change in visual attention and task switching using the Trail Making A and B test

    Time frame: From baseline to 8-weeks

    This cognitive task measures the time to complete the task and errors made.

    In Trail Making Test A, a longer completion time and higher number of errors can indicate difficulties with processing speed and attention.

    In Trail Making Test B, a longer completion time and a higher number of errors on Trail Making Test B, compared to Trail Making Test A, can indicate difficulties with cognitive flexibility, mental shifting, and attention.

  5. Change in selective attention using the Stroop Test

    Time frame: From baseline to 8-weeks

    This cognitive task measures the time to complete the task and errors made. A longer completion time and a higher number of errors can indicate difficulty with selective attention and mental flexibility.

Secondary outcomes

  1. Change in suicidal ideation using the Beck Scale for Suicide Ideation (BSSI)

    Time frame: From baseline to 8-weeks

    A 21-item self-report scale that quantifies suicidal ideation. The BSSI is a Likert-style questionnaire, where each item is rated on a scale from 0 to 3, with higher scores indicating a greater severity of suicidal thoughts and behaviours. The minimum possible score on the BSSI is 0, which would indicate the absence of suicidal ideation. The maximum possible score is 63, which would indicate a high level of severity of suicidal thoughts and behaviours.

  2. Changes in affect using the Positive and negative affect schedule - short form (PNAS-SF)

    Time frame: From baseline to 8-weeks

    A 10-item scale to assess the experience of positive and negative emotions/feelings. Each item is rated on a 5-point Likert scale, ranging from 1 (very slightly or not at all) to 5 (extremely).

    The minimum possible score on the PNAS-SF for positive affect is 10, which would indicate the absence of positive affect. The maximum possible score is 50, which would indicate a high level of positive affect.

    The minimum possible score on the PNAS-SF for negative affect is 10, which would indicate the absence of negative affect. The maximum possible score is 50, which would indicate a high level of negative affect.

  3. Changes in depression symptoms using the Quick Inventory of Depressive Symptomatology - self-report (QIDS-SR).

    Time frame: From baseline to 8-weeks

    A 16-item validated depression scale. Each item is rated on a 4-point Likert scale, ranging from 0 (not at all) to 3 (severe).

    The minimum possible score on the QID-SR is 0, which would indicate the absence of depression. The maximum possible score is 48, which would indicate a high level of depression severity.

  4. Changes in quality of life using the Quality of Life Scale (QOLS)

    Time frame: From baseline to 8-weeks

    A validated 16-item scale to assess quality of life. Each item is rated on a 7-point Likert scale , ranging from 1 (terrible) to 7 (delighted).

    The minimum possible score on the QOLS is 16, which would indicate poor quality of life. The maximum possible score is 112, which would indicate excellent quality of life.

  5. Feasibility and acceptability of music-based cognitive training

    Time frame: From baseline to 8-weeks

    Feasibility and Acceptability survey and interview created in-house with questions designed to collect quantitative and qualitative feedback from participants with respect to the feasibility and acceptability of the music-based cognitive training intervention.

Sponsors and collaborators

Lead sponsor

Unity Health Toronto

Other

Registry information

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Jan 23, 2023
Registry last updated
Mar 4, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.